1. Home
  2. RVPH vs HUHU Comparison

RVPH vs HUHU Comparison

Compare RVPH & HUHU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPH
  • HUHU
  • Stock Information
  • Founded
  • RVPH 2006
  • HUHU 2015
  • Country
  • RVPH United States
  • HUHU China
  • Employees
  • RVPH N/A
  • HUHU N/A
  • Industry
  • RVPH Biotechnology: Pharmaceutical Preparations
  • HUHU
  • Sector
  • RVPH Health Care
  • HUHU
  • Exchange
  • RVPH Nasdaq
  • HUHU NYSE
  • Market Cap
  • RVPH 88.0M
  • HUHU 92.9M
  • IPO Year
  • RVPH N/A
  • HUHU 2024
  • Fundamental
  • Price
  • RVPH $2.07
  • HUHU $3.92
  • Analyst Decision
  • RVPH Strong Buy
  • HUHU
  • Analyst Count
  • RVPH 5
  • HUHU 0
  • Target Price
  • RVPH $11.40
  • HUHU N/A
  • AVG Volume (30 Days)
  • RVPH 2.1M
  • HUHU 29.2K
  • Earning Date
  • RVPH 11-14-2024
  • HUHU 02-22-2025
  • Dividend Yield
  • RVPH N/A
  • HUHU N/A
  • EPS Growth
  • RVPH N/A
  • HUHU 13.14
  • EPS
  • RVPH N/A
  • HUHU 0.08
  • Revenue
  • RVPH N/A
  • HUHU $17,492,735.00
  • Revenue This Year
  • RVPH N/A
  • HUHU N/A
  • Revenue Next Year
  • RVPH N/A
  • HUHU N/A
  • P/E Ratio
  • RVPH N/A
  • HUHU $50.43
  • Revenue Growth
  • RVPH N/A
  • HUHU 33.03
  • 52 Week Low
  • RVPH $0.60
  • HUHU $3.52
  • 52 Week High
  • RVPH $4.83
  • HUHU $9.89
  • Technical
  • Relative Strength Index (RSI)
  • RVPH 59.47
  • HUHU N/A
  • Support Level
  • RVPH $1.78
  • HUHU N/A
  • Resistance Level
  • RVPH $1.91
  • HUHU N/A
  • Average True Range (ATR)
  • RVPH 0.16
  • HUHU 0.00
  • MACD
  • RVPH 0.01
  • HUHU 0.00
  • Stochastic Oscillator
  • RVPH 82.98
  • HUHU 0.00

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

About HUHU HUHUTECH INTL GROUP INC

HUHUTECH International Group Inc specializes in providing factory facility management and monitoring systems, including high-purity gas, chemicals and liquid system and factory management and control systems for industrial clients, who are mainly semi-conductor manufacturers and electronics manufacturers in China. The products and services are widely used by semi-conductor manufacturers, LED and micro-electronics factories, as well as some pharmaceutical, food and beverage manufacturers.

Share on Social Networks: